{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:56:00Z","timestamp":1789088160648,"version":"build-2803163510"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>The traditional syphilis screening algorithm, which involves a nontreponemal assay followed by confirmatory treponemal testing, has been challenged by an alternative approach known as the reverse sequence algorithm. The latter reverses the order of the tests and incorporates a second treponemal test for discordant results. Although the reverse sequence may offer operational advantages, there is a need for formal cost-effectiveness analyses to compare these two syphilis screening alternatives.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>We conducted cost-effectiveness analyses from the health care sector perspective to compare the reverse sequence with the traditional algorithm. We employed a decision tree for pregnant women in prenatal care that included the possibility of congenital syphilis outcomes. A simulated a cohort of 10,000 people was screened over 1 year to estimate total costs and quality-adjusted life-years (QALYs) under each algorithm. We estimated incremental cost-effectiveness ratios (ICERs). Sensitivity analyses were performed to identify influential parameters affecting the ICERs and to conduct scenario analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>During prenatal care, the reverse sequence detected four more cases, overtreated 185 more individuals, and prevented 0.42 more congenital syphilis cases (ICER $463,735\/QALY gained), when compared with the traditional algorithm. Sensitivity analyses revealed that syphilis prevalence had the greatest effect on the ICER. To achieve ICERs below $50,000\/QALY gained, syphilis prevalence would need to exceed 6% during prenatal care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>Our analysis indicates that, under likely parameter values, the reverse sequence algorithm is equally effective but more costly than the traditional algorithm and therefore not cost effective. Although treponemal test automation may offer potential savings in laboratory costs, these are outweighed by overtreatment costs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aog.0000000000006019","type":"journal-article","created":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T21:06:34Z","timestamp":1754600794000},"page":"795-805","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Cost Effectiveness of the Reverse Sequence Algorithm Compared With the Traditional Algorithm for Syphilis Screening Among Pregnant Women"],"prefix":"10.1097","volume":"146","author":[{"given":"Enrique M.","family":"Saldarriaga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily D.","family":"Pollock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas L.","family":"Gift","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindley A.","family":"Barbee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura H.","family":"Bachmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian H.","family":"Spicknall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,8,7]]},"reference":[{"key":"R1-20260824","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.15585\/mmwr.mm7246e1","article-title":"Vital signs: missed opportunities for preventing congenital syphilis\u2014United States, 2022","volume":"72","author":"McDonald","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R2-20260824","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7004a1","article-title":"Sexually transmitted infections treatment guidelines, 2021","volume":"70","author":"Workowski","year":"2021","journal-title":"MMWR Recomm Rep"},{"key":"R3-20260824","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7301a1","article-title":"CDC laboratory recommendations for syphilis testing, United States, 2024","volume":"73","author":"Papp","year":"2024","journal-title":"MMWR Recomm Rep"},{"key":"R4-20260824","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.clinmicnews.2014.12.001","article-title":"Serologic testing for syphilis: benefits and challenges of a reverse algorithm","volume":"36","author":"Soreng","year":"2014","journal-title":"Clin Microbiol Newsl"},{"key":"R5-20260824","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1093\/cid\/ciy558","article-title":"Performance of treponemal tests for the diagnosis of syphilis","volume":"68","author":"Park","year":"2019","journal-title":"Clin Infect Dis"},{"key":"R7-20260824","doi-asserted-by":"crossref","first-page":"661","DOI":"10.15585\/mmwr.mm6922a1","article-title":"Missed opportunities for prevention of congenital syphilis\u2014united States, 2018","volume":"69","author":"Kimball","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R8-20260824","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1001\/jama.2016.12195","article-title":"Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: Second panel on cost-effectiveness in health and medicine","volume":"316","author":"Sanders","year":"2016","journal-title":"JAMA"},{"key":"R9-20260824","doi-asserted-by":"crossref","first-page":"e810","DOI":"10.1093\/cid\/ciac427","article-title":"Estimation of the lifetime quality-adjusted life years (QALYs) lost due to syphilis acquired in the United States in 2018","volume":"76","author":"Lee","year":"2023","journal-title":"Clin Infect Dis"},{"key":"R10-20260824","doi-asserted-by":"crossref","first-page":"381.e1","DOI":"10.1016\/j.ajog.2015.10.007","article-title":"Congenital syphilis: trends in mortality and morbidity in the United States, 1999 through 2013","volume":"214","author":"Su","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"R12-20260824","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1001\/jama.2016.4114","article-title":"Screening for syphilis: updated evidence report and systematic review for the US preventive services task force","volume":"315","author":"Cantor","year":"2016","journal-title":"JAMA"},{"key":"R13-20260824","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00003081-197503000-00016","article-title":"Syphilis in newborn children","volume":"18","author":"Fiumara","year":"1975","journal-title":"Clin Obstet Gynecol"},{"key":"R14-20260824","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1212\/01.CPJ.0000435752.17621.48","article-title":"Diagnostic tests for syphilis","volume":"4","author":"Henao-Mart\u00ednez","year":"2014","journal-title":"Neurol Clin Pract"},{"key":"R15-20260824","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1177\/0272989X12458348","article-title":"Model parameter estimation and uncertainty analysis: a report of the ISPOR-SMDM modeling good research practices task force working Group-6","volume":"32","author":"Briggs","year":"2012","journal-title":"Med Decis Making"},{"key":"R16-20260824","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1056\/NEJMp1405158","article-title":"Updating cost-effectiveness\u2014the curious resilience of the $50,000-per-QALY threshold","volume":"371","author":"Neumann","year":"2014","journal-title":"N Engl J Med"},{"key":"R18-20260824","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v028.i05","article-title":"Building predictive models in R using the caret package","volume":"28","author":"Kuhn","year":"2008","journal-title":"J Stat Softw"},{"key":"R19-20260824","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/OLQ.0b013e3181ec51f1","article-title":"Serologic testing for syphilis in the United States: a cost-effectiveness analysis of two screening algorithms","volume":"38","author":"Owusu-Edusei","year":"2011","journal-title":"Sex Transm Dis"},{"key":"R20-20260824","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1097\/OLQ.0000000000000875","article-title":"Economic assessment of reverse algorithm syphilis screening in a high prevalence population","volume":"45","author":"Buono","year":"2018","journal-title":"Sex Transm Dis"},{"key":"R21-20260824","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/CMR.8.1.1","article-title":"Laboratory diagnosis and interpretation of tests for syphilis","volume":"8","author":"Larsen","year":"1995","journal-title":"Clin Microbiol Rev"},{"key":"R22-20260824","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/OLQ.0b013e3182036a0f","article-title":"The tale of two serologic tests to screen for syphilis\u2013treponemal and nontreponemal: does the order matter?","volume":"38","author":"Owusu-Edusei","year":"2011","journal-title":"Sex Transm Dis"},{"key":"R23-20260824","doi-asserted-by":"crossref","first-page":"93","DOI":"10.5858\/2016-0110-CP","article-title":"Prevalence of traditional and reverse-algorithm syphilis screening in laboratory practice: a survey of participants in the college of American pathologists syphilis serology proficiency testing program","volume":"141","author":"Rhoads","year":"2017","journal-title":"Arch Pathol Lab Med"},{"key":"R24-20260824","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/OLQ.0000000000001101","article-title":"Testing for sexually transmitted diseases in US public health laboratories, 2016","volume":"47","author":"Davis","year":"2020","journal-title":"Sex Transm Dis"},{"issue":"suppl 1","key":"R25-20260824","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1093\/cid\/ciaa307","article-title":"The traditional or reverse algorithm for diagnosis of syphilis: pros and cons","volume":"71","author":"Ortiz","year":"2020","journal-title":"Clin Infect Dis"},{"key":"R26-20260824","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1524-4733.2005.08101.x","article-title":"Probabilistic analysis of cost-effectiveness models: statistical representation of parameter uncertainty","volume":"8","author":"Briggs","year":"2005","journal-title":"Value Health"},{"key":"R27-20260824","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1177\/0272989X12454577","article-title":"Modeling good research practices\u2014overview: a report of the ISPOR-SMDM modeling good research practices task Force\u20131","volume":"32","author":"Caro","year":"2012","journal-title":"Med Decis Making"},{"key":"R29-20260824","doi-asserted-by":"crossref","first-page":"e00898-19","DOI":"10.1128\/JCM.00898-19","article-title":"Frequency and characteristics of biological false-positive test results for syphilis reported in Florida and New York City, USA, 2013 to 2017","volume":"57","author":"Matthias","year":"2019","journal-title":"J Clin Microbiol"},{"key":"R30-20260824","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/OLQ.0000000000001353","article-title":"The estimated lifetime medical cost of syphilis in the United States","volume":"48","author":"Chesson","year":"2021","journal-title":"Sex Transm Dis"},{"key":"R31-20260824","doi-asserted-by":"crossref","first-page":"267.e1","DOI":"10.1016\/j.ajog.2013.12.012","article-title":"Cost and clinical utility of repeated syphilis screening in the third trimester in a high-risk population","volume":"210","author":"Shiber","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"R32-20260824","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1067\/mob.2002.122450","article-title":"Costs and consequences of comprehensive stillbirth assessment","volume":"186","author":"Michalski","year":"2002","journal-title":"Am J Obstet Gynecol"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000006019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T13:12:56Z","timestamp":1787577176000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000006019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,7]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000006019","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,7]]},"assertion":[{"value":"2025-02-27","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-05","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}